Renovaro Biosciences
RENB
#8804
Rank
โ‚น10.82 B
Marketcap
โ‚น68.22
Share price
-4.99%
Change (1 day)
-81.42%
Change (1 year)

Earnings for Renovaro Biosciences (RENB)

Earnings in 2024 (TTM): -โ‚น12.52 Billion

According to Renovaro Biosciences's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚น3.55 Billion, an increase over its 2022 earnings that were of -โ‚น9.35 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Renovaro Biosciences from 2012 to 2024

2013201620192022- โ‚น10B- โ‚น5Bโ‚น5B0companiesmarketcap.com

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น12.52 Billion252.46%
2023 -โ‚น3.55 Billion-62.03%
2022 -โ‚น9.35 Billion182.88%
2021 -โ‚น3.31 Billion246.9%
2020 -โ‚น0.96 Billion614.13%
2019 -โ‚น0.14 Billion-93.65%
2018 -โ‚น2.11 Billion1119.78%
2017 -โ‚น0.18 Billion-29.21%
2016 -โ‚น0.25 Billion
2014 -โ‚น0.23 Billion6701.79%
2013 -โ‚น3.25 Million16.61%
2012 -โ‚น2.79 Million